is a preclinical drug delivery and RNA medicines company. Focused on developing novel technologies to build the next generation of safe, effective RNA and DNA medicines. Arcturus has proprietary technologies, validating partnerships, and an experienced team with deep expertise in delivery and RNA-based therapeutics. We proudly have their equipment locations mapped into the CBV app to ensure minimal facility disruptions.
Pacira has established itself as a leading provider of non-opiod pain management and regenerative health solutions. Their in-depth knowledge of non-opioid pain management, coupled with passion for delivering improved patient care, drives their commitment to providing solutions that address unmet medical needs and improve clinical results. Pacira entered CBV at its infancy, and potentially grow with our app.
Nitto BioPharma develops unique drug delivery solutions including molecular targeting Drug Delivery Systems (DDS) for the treatment of Fibrosis. Nitto BioPharma’s mission is to develop and deliver innovative life-transforming therapies for patients with unmet medical needs. Leveraging the long-standing success and track record of Nitto Denko Corporation, Nitto BioPharma has created an efficient business unit to enable pharmaceutical products to be brought to market at a fast pace. Nitto supported CBV in it's earliest stages and continues to maintain a strong relationship into the future.
Gradlabs is a multi-tenant biomedical building under the guidance of Alexandria Real Estate. In multi-tenant building's the procedure is the same for single tenants, with the caveat that the information will be accessible to the real estate company rather than one, single Bio-Tech company.
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases. The engineering staff at Vertex has provided CBV with tremendous testing for the app and will likely be a core partner in the future.
Takeda, a forward-looking, world-class R&D organization that unlocks innovation and delivers transformative therapies to patients. Through focused R&D efforts across therapeutic areas and targeted investments, Takeda pushes the boundaries of what is possible in order to bring life-changing therapies to patients worldwide. Takeda was one of first to utilize the CBV app. They have been critical to the evolution of client based feedback for the app.
Over the last 25 years, Alexandria Real Estate has established themselves as a leader in owning, operating, and developing collaborative and dynamic life science, technology, and agtech campuses in key urban innovation cluster locations. CBV and ARE are currently in partnership which has been a driving factor for CBV app innovation.
